Introduction
Cellular therapy is a mainstay in the treatment of oncologic and hematologic diseases and it offers hope for a very large range of other diseases and disorders. Among the various stem cell populations used for cell therapy, adult mesenchymal stem cells (MSC, also referred to as mesenchymal stromal cells) have emerged as a major new cell technology with a diverse spectrum of potential clinical applications. 1, 2 At least 92 clinical trials are currently using MSC worldwide (http://clinicaltrials.gov/).
The results of preclinical and clinical studies paint a promising picture for stem cell-based therapies, and consequently, there are tremendous expectations for stem cell research. However, many important questions persist relating to the in vivo fate of transplanted stem cells. Translational research in experimental animal models is essential, with a critical emphasis on developing methods for monitoring the viability, as well as the temporal and spatial homing of these cells to target tissue.
Magnetic resonance imaging (MRI) has emerged as an excellent method for tracking cells in vivo. Many cell tracking studies have used iron oxide nanoparticle-based contrast agents to label cells for detection with MRI. Iron-labeled cells appear as distinct regions of signal hypointensity (signal loss) in images. The sensitivity for detection of iron-labeled cells is very high. Even single iron-labeled cells can be visualized in vivo under some conditions. 3, 4 A challenge encountered with iron-based cell tracking is that other endogenous sources of signal loss also appear in images that are sensitive to iron (for example due to blood, hemosiderin, bone, and air) making it difficult to unambiguously identify regions containing labeled cells. 5 In addition, iron-labeled cell quantification is difficult. We, and others, have shown that the contrast generated by ironlabeled cells increases with the amount of iron/voxel but that this is only linear at low iron loadings; the change in contrast reaches a saturation plateau at higher iron loadings. 6, 7 When quantifying the presence of iron-labeled stem cells over time, most studies measure the "signal void volume" 8, 9 or the "number of black pixels", 10, 11 and present the change relative to the first imaging time point.
Perfluorocarbon (PFC) nanoemulsion formulations have also been used, to a more limited extent, for fluorine-19 ( 19 F) MRI cell tracking. 12 One of the key advantages of these agents is the very high specificity; since this atom is mainly absent from the body, there is no background 19 F signal in MR images. In addition, the fluorine signal can be accurately quantified from the MR images by comparing the 19 F signal in the tissue of interest to an external reference containing a known amount of fluorine atoms. Finally, unlike iron nanoparticles, perfluorocarbon nanoemulsions are biologically inert. Common enzymes do not cleave the bond between carbon and fluorine. 13 Fluorine-based compounds are already used in patients as blood substitutes and their safety is wellestablished. 14, 15 Furthermore, the number of fluorine atoms that are internalized by cells after labeling is several orders of magnitude lower than what is typically used in artificial blood substitutes.
Examples of 19 F MR imaging performed to date include: monitoring inflammation (tumor models, rheumatoid arthritis, lung injuries, and after ischemia in the lung or brain), [16] [17] [18] [19] detection of T cell and dendritic cell migration, 20, 21 and tracking the fate of transplanted hematopoietic and neural stem cells.
22-24
The main limitation of 19 F cell tracking is its relatively low sensitivity when compared to cellular imaging with iron nanoparticles. In this paper, we compare 19 F-and ironbased methods for MSC tracking in vivo. Our specific goals were: 1) to evaluate the use of a balanced steady-state free precession (bSSFP) sequence for 19 F cell tracking; 2) to demonstrate that primary human MSC (hMSC) could be labeled with a sufficient quantity of the 19 F agent, Cell Sense, to allow for cell detection, without altering cell viability or differentiation; and 3) to compare the information obtained from imaging iron-and 19 F-labeled hMSC after intramuscular (IM) injection in healthy mice.
Materials and methods
Human mesenchymal stromal cell culture and labeling hMSC came from bone marrow donated by healthy young adult volunteers after written informed consent according to a protocol approved by the University Health Network Research Ethics Board (Toronto, ON, Canada). 25 MSC were grown until passage 4. The cells were cultured in Dulbecco's Modified Eagle's Medium low glucose, 2 mM of L-glutamine, 12.5% fetal bovine serum, and 100 u/mL of penicillin and streptomycin. The cells were passaged twice before labeling and injection into mice.
hMSC were labeled with both iron-based and
19
F-based agents. The iron-based agent was Molday ION Rhodamine-B (MIRB), an ultra-small iron oxide nanoparticle (BioPal, Worcester, MA, USA). MIRB has a colloidal size of 35 nm, a zeta potential of +31 mV and is cross-linked and labeled with Rhodamine B, allowing visualization by MRI and fluorescence microscopy. The 19 F-based agent was Cell Sense (CS-1000), a perfluoropolyether (PFPE) nanoparticle (Celsense Inc., Pittsburg, PA, USA). Cell Sense is an aqueous colloidal suspension (ie, nanoemulsion) of a PFPE perfluorocarbon polymer, having a total fluorine content of 145 mg/mL. The average nanoemulsion droplet size is 180 nm. Cell Sense is formulated with excipients that expedite entry of the nanomaterial into all cell types, regardless of their ability to phagocytose. The PFPE molecule used in Cell Sense is both lipophobic and hydrophobic and stable at low pH. 20 In some cases, a red fluorescent version of this PFPE was used (CS-ATM-DM Red).
Cell Sense was added to the cell culture medium at a concentration of 2.5 mg/mL and incubated with the hMSC for 24 hours. MIRB was incubated with hMSC at a concentration of 50 µg/mL for 24 hours. 26 After this incubation period, the cells were washed three times with Hank's balanced salt solution (HBSS [Life Technologies, Carlsbad, CA, USA]), harvested with Trypsin, spun down, and counted.
To evaluate the amount of 19 F internalized by the hMSC, the Cell Sense-labeled cells were fixed overnight with 4% paraformaldehyde (PFA) then lysed by sonication using 200 µL of 1% Triton X-100 (Sigma-Aldrich, St Louis, MO, USA) and incubation for 4 hours at room temperature in a sonication bath. This solution was then placed into International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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bSSFP detection of fluorine-labeled human MSC a glass nuclear magnetic resonance (NMR) tube (5 mm diameter), to which 200 µL of D 2 O and 100 µL of 0.1% trifluoroacetic acid (TFA) was added. 19 F-spectroscopy was then performed at 400 MHz on a vertical scanner using the following parameters: TR =7 seconds; rBW =18859 Hz; NEX =100; line broadening =5 Hz, spectral range from −68 ppm to −93 ppm. The ratio of the areas under the TFA and the Cell Sense-labeled hMSC peaks were calculated to determine the amount of fluorine atoms per cell, as described by Srinivas et al. 21 hMSC differentiation assay
To assess the effect of Cell Sense labeling on hMSC differentiation, hMSC were cultured in six-well plates until they reached 70% or 100% confluency for adipogenic and osteogenic differentiation assays, respectively. Then, three wells were incubated with 2.5 mg/mL of Cell Sense nanoparticles for 24 hours and the other three wells were used for the unlabeled hMSC condition. The wells were washed three times with HBSS before adipogenic or osteogenic media was added (StemXVivoTM Osteogenic/Adipogenic Base Media supplemented with StemXVivoTM Osteogenic Supplement or StemXVivoTM Adipogenic Supplement; R&D Systems, Inc., Burlington, ON, Canada). Fresh media was replaced every 3-4 days. After 3 weeks, the cells were stained with either Oil red O, to identify lipid vesicles, or Alizarin Red S to identify extracellular calcification drops.
The cells were examined using a Zeiss AXIO Imager A1 microscope (Carl Zeiss Canada Ltd, Toronto, ON, Canada). The number of adipocytes per condition (unlabeled and Cell Sense-labeled hMSC) were counted in five fields of view (FOV) per well (three wells per condition), and the mean of these taken. Osteogenesis was evaluated by qualitatively comparing the number of extracellular calcification drops in each well.
MRI sequence
All MRI was performed on a 9.4 T Varian small-animal MRI scanner equipped with a custom-built dual-tuned proton/fluorine birdcage coil (diameter =2.2 cm, length =5.1 cm; Agilent, Santa Clara, CA, USA). The coil was tuned to 400.2 MHz for proton imaging and 376.8 MHz for fluorine imaging. A 3D bSSFP sequence was evaluated for fluorine detection using cell samples containing different numbers of Cell Sense-labeled hMSC (2×10 ) pelleted after fixation in 4% PFA. The bSSFP parameters were: TR =2.7 milliseconds; FA =70°, rBW =25 kHz; FOV =32×24×36 mm; matrix =32×24×18; resolution =1×1×2 mm; NEX =950; 1 hour 17 minutes. Afterwards, NEX was reduced by half (475) to examine the influence of this parameter on the detection limit (acquisition time was thus shorter at 38 minutes).
In vivo MRI of implanted hMSC
Cell Sense-labeled hMSC at 1.5×10 6 and MIRB-labeled hMSC at 1.5×10 6 (in 100 µL HBSS/mouse) were injected IM into the right and left hind limb, respectively, in six female nude mice (nu/nu Foxn1 mice, 6-7 weeks old; Charles River Laboratories, Wilmington, MA). These injections were performed while under inhalational anesthesia (isoflurane, 1%) that lasted less than 5 minutes per mouse. For MRI, the mice were anesthetized with an intraperitoneal injection of pentobarbital (65 mg/kg) to avoid detecting isoflurane on the 19 F MR images. Four of the six mice were imaged on days 0 (4-6 hours after the injection), 3, and 12 after injection. Two of the six mice were imaged on days 0, 3, 12, 17, and 26 days post-injection. A reference tube containing 2.6×10 16 19 F atoms/µL was always inserted into the coil with the mice.
The bSSFP parameters were the same as for the hMSC pellets but with NEX =750 and a scan time of around 1 hour. The corresponding proton images were also acquired using bSSFP, for anatomical localization of the 19 F signal and to visualize the iron-labeled hMSC, with the following parameters: TR =8 milliseconds; FA =30°; rBW =125 kHz; resolution =200×200×200 µm; eight phase cycles; NEX =2; 46 minutes. All experiments were approved by the Western University Animal Use Committee.
analysis The 19 F images were analyzed using Voxel Tracker™ software (Celsense Inc.) and the fluorine signal was quantified by comparison with the signal generated by the reference tube containing a known amount of Cell Sense nanoparticles (2.6×10 16 19 F/µL). The amount of fluorine atoms measured at day 0 was set to 100% and for each mouse, the amounts measured at day 3 and day 12 were normalized to day 0. The signal void volume due to the presence of MIRB-labeled hMSC was measured from the 1 H images using the image analysis program Osirix (Pixmeo SARL, Bernex, Switzerland). 27 The volume of the void measured at day 0 was set to 100% and for each mouse, the void volumes measured at day 3 and day 12 were normalized to day 0. For both fluorine and iron quantifications, regions of interest (ROIs) were hand-drawn around the voxels containing fluorine or void signals. ROIs were drawn on every MR slice where the signals appeared. Student's t-tests were performed.
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Immunohistochemistry staining
At endpoint, the mice were sacrificed and perfused with 4% formalin. The hind limb muscles were extracted and cryoprotected with increasing concentrations of sucrose before being frozen and cut into 16 µm sections using a cryostat. Non-specific binding was blocked using 10% normal goat serum (Vector Laboratories, Burlingame, CA, USA) and 0.1% Triton-X-100 (Sigma-Aldrich) in PBS for 1 hour at room temperature. Sections were washed with PBS. Then they were incubated overnight at 4°C with the mouse antihuman Golgi zone (Chemicon International, Temecula, CA, USA) diluted at 1/500 in blocking solution (as described by Gordon et al). 28 Slides were mounted in Vectashield containing 4,6-diamidino-2-phenylindole (DAPI; Vector Laboratories).
Results
Labeling of hMSC with Cell Sense
After an incubation of 24 hours, hMSC internalized high amounts of the Cell Sense agent, without the need for transfection agents, as visualized by fluorescence microscopy ( Figure 1 ). The Cell Sense particles are located within the cytoplasm and more precisely into vesicles, as seen by the granulated shape of the fluorescence in Figure 1C . NMR experiments demonstrated that the hMSC internalized 7.1±1.7×10 10 19 F atoms/cell on average. Labeling the hMSC with Cell Sense did not affect differentiation into osteocytes or adipocytes (Figure 2 ). The amount of calcification drops secreted in the extracellular medium appeared similar for unlabeled ( Figure 2A ) and labeled hMSC ( Figure 2B ). There was no significant difference between the number of adipocytes counted for unlabeled and Cell Sense-labeled hMSC ( Figure 2C and D) .
In vitro detection of cell Sense-labeled hMSC using bSSFP
The minimum number of Cell Sense-labeled hMSC required for detection using a 3D-bSSFP sequence was analyzed in vitro with Cell Sense-labeled hMSC pellets imaged at 9.4 T. Two slices that cut through the 2×10 5 pellets (top row, right) are shown in Figure 3A . All cell pellets were easily detected with 1 hour scans. The quantification of the fluorine signal ( Figure 3B ) confirmed that the relationship between the cell numbers and the amount of fluorine atoms detected by the bSSFP sequence is linear (with a correlation factor R 2 of 0.82). The same bSSFP sequence was performed on the pellets, with half of the signal averages (and so half the scan time) ( Figure 3A, lower row) . All of the cell pellets were still visible except for 2×10 5 hMSC (dashed circle). Thus, all further images were performed using the higher number of averages (750), but limiting scan time to 1 hour for the in vivo experiments, as is usually performed for small animal imaging.
20,23,24
In vivo detection of Cell Sense-and MIRB-labeled hMSC
Each nude mouse received injections of Cell-Sense-and MIRB-labeled hMSC in their left and right thigh muscles, respectively. Figure 4A shows the proton image of an axial slice located at the level of the groin for a representative mouse, acquired on the day of the injection (day 0). The injection site of the Cell Sense-labeled hMSC could be detected on the proton image as an area slightly more hyper-intense than the surrounding muscle (red arrow), due to saline. The corresponding fluorine image is shown in Figure 4B , where only the end of the reference tube and the injected labeled cells were detected. Figure 4C shows the overlay between the proton and the fluorine images, allowing for precise location of the injected cells in the mouse body.
As shown in Figure 4D -F, the fluorine signal can be tracked over time in the muscle (D at day 3, E at day 12, F at day 26 post-injection). The total amount of 19 F atoms localized at the injection site (shown at the top of each image) decreased over time, likely due to hMSC death and clearance from the mouse body.
The MIRB-labeled hMSC injected on the opposite side could also be easily detected through the visualization of the area of signal loss in the muscle ( Figure 4D -F, blue arrows). It should be noted, however, that the bones in the 
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Ribot et al mouse legs also appeared as signal loss (yellow arrow). Endogenous sources of signal loss such as this can confuse the interpretation of contrast attributed to the presence of iron-labeled cells. For both Cell Sense-labeled and MIRBlabeled hMSC, the injected cells were visible at the site of their injection over the period of time that the mice were scanned (26 days) and were not detected in other locations or organs.
The signal due to the implanted hMSC was quantified for both cell labels at each imaging time point. For MIRB-labeled cells, the volume of the void area induced by the presence of MIRB-labeled hMSC was measured ( Figure 5A ). There was a significant 20% decrease in the void volume noticeable at day 12 (P=0.044 between day 0 and day 12). For Cell Sense-labeled cells, the fluorine signal was quantified by comparing the signal within the ROI to the signal from the external reference tube ( Figure 5B ). The SNR of the 19 F-hMSC was higher than 7 at all imaging time points, allowing for accurate detection for at least 26 days after the injections. The number of 19 F atoms also significantly decreased with time (P=0.004 between day 0 and day 12; P=0.025 between day 3 and day 12). At day 12, the fluorine signal was approximately 50% of that at day 0. This decrease was greater than the one measured from the MIRB-labeled cells.
Microscopy of muscle tissue
Mice were sacrificed 26 days after the cell injections. Fluorescence microscopy demonstrated that the location of the hMSC corresponded with the location of the red fluorescence-tagged Cell Sense nanoparticles ( Figure 6A ). Immunohistochemistry staining against human Golgi verified the presence of the hMSC at the injection site, next to the muscle fibers ( Figure 6B ).
Discussion
In this study, we show that efficient labeling of hMSCs with a PFPE-based marker is possible without impacting cell viability or differentiation. This result agrees with other studies that demonstrate the ability of hMSC to internalize iron nanoparticles such as MIRB without cytotoxicity or affecting stem cell differentiation. 26, 29 Others have also shown that Cell Sense does not impact the phenotype or functioning of dendritic cells 12 or differentiation in other stem cell types. 22, 23 We have also successfully demonstrated in vivo detectability of hMSC labeled with the only fluorine-based contrast agent that has been FDA-approved for cellular imaging, using the 3D-bSSFP imaging sequence. This is the first study to monitor the fate of hMSC using 19 F MRI.
Cell detection with bSSFP
The image SNR is key to the ability to detect PFPE-labeled cells by 19 F MRI. One important finding from this work was that 19 F-labeled human stem cells can be detected and tracked over time with the bSSFP imaging sequence at high magnetic field. It has already been demonstrated that bSSFP is the most SNR efficient pulse sequence in use. 30 Proof of principle that bSSFP was advantageous for the detection of 19 F-labeled stem cells has been previously reported by Partlow et al. 31 In this paper, a liquid PFC was developed and used to label stem/ progenitor cells in culture. A single mouse then received an IM injection of 4 million fixed PFC-labeled cells and was imaged after euthanasia at 1.5 T with 2D bSSFP. To the best of our knowledge, this is the only other published report on the use of bSSFP sequence to detect 19 F-labeled cells after transplantation.
Two other groups have utilized the high SNR engendered by the 3D bSSFP sequence along with the intravenous injection of the perfluorocarbon V-Sense to study inflammation. [32] [33] [34] [35] [36] However, these studies used a chemical shift imaging (CSI) approach with bSSFP to allow for visualization of the different spatial distributions of chemically shifted PFC compounds. Overall, the vast majority of studies that perform cell tracking with 19 F MRI have employed spin echo sequences. [16] [17] [18] [19] [37] [38] [39] [40] Using the 3D bSSFP sequence, we injected and detected 1.5×10 6 Cell Sense-labeled hMSC in vivo on day 0 using a spatial resolution of 2 mm 3 (2 µL). If we assume that on day 0 all of the injected cells are present and evenly distributed, then we detected 30,000 cells per voxel. The literature reports a wide range of detection thresholds for 19 F-labeled cells, and the various studies use a range of parameters to perform the cell labeling and MRI. This sensitivity of detection will vary depending on MRI factors (magnetic field strength, pulse sequence, voxel size, radiofrequency coil) and on cell labeling efficiency, which is influenced both by the type of label used and by the cell-labeling protocol. For example, Partlow et al injected and detected 4 million cells in 50 µL at 1.5 T ex vivo. 31 The voxel size was 2.5×2.5×35 mm (∼220 µL); therefore, they detected 4 million cells in a voxel. They did this in a far shorter imaging time of 7 minutes compared to our 40 minutes. Higher resolution imaging would have resulted in fewer cells/voxel, and consequently, increased scan time.
In vivo detection of cell Sense-labeled hMSC over time Our in vivo data demonstrated that 1.5×10 6 hMSC were easily detected soon after IM injection (within hours on day 0). Three days post-implantation, the number of labeled cells at the implantation site was not significantly different from day 0. Between days 3 and 12 post-implantation, we observed a significant decrease in the signal. A continual gradual decline in the 19 F signal was observed until day 26 post-implantation. The MRI signal persisted for at least 26 days and fluorescence microscopy validated the presence of Cell Sense-positive hMSC remaining at the site of cell implantation. The fact that the fluorine signal was still easily detectable and quantifiable as long as 26 days post-injection is likely because the hMSC were implanted in healthy tissue in immunocompromised mice. In diseased tissue and immunocompetent recipients, the rate of cell death would be expected to be greater.
Only a few other studies have used MRI to detect 19 F-labeled stem cells in vivo, and only three studies have performed imaging at multiple time points to monitor their fate after transplantation. Boehm-Sturm et al first demonstrated that the fluorine signal changes by less than 20% from day 2 and day 6 after the implantation of 150,000 human neural stem cells (NSCs) directly into the striatum in healthy mice. 23 Ruiz-Cabello et al imaged mouse NSCs implanted into normal mouse striatum and showed that the 19 F signal remained constant for 1 week post-implantation and was diminished but still visible for up to 2 weeks. 41 Histopathology showed that the labeled cells remained viable and that labeled cells had migrated from the site of implantation into the brain parenchyma. Most recently, Bible et al used 19 F MRI to monitor the fate of human NSCs suspended in a bioscaffold transplanted into the lesion cavity in a rat model of stroke. 24 The area covered by the 19 F signal decreased between days 1 and 7. Our results with hMSCs are in agreement with these other longitudinal imaging studies that demonstrate the robust early detection of transplanted cells followed by a decline in the 19 F signal that may be due to cell division or cell death. However, they contrast with the study by Helfer et al, where 14×10
6 Cell Sense-labeled human hematopoietic stem cells (HSCs) either trapped in matrigel or suspended in PBS were imaged after being implanted into the rat hind limb muscle. 22 Surprisingly, 2 hours post-implantation, a 19 F signal was only detected in the rat implanted with the matrigel containing labeled cells, although eight times more labeled cells were injected compared to our study. This observation may suggest a notable difference in the in vivo fate of intramuscular (IM) transplanted HSC.
comparison of signal from 19 
F-versus iron-labeled cells
This is the first study to compare the change in signal due to iron-versus 19 F-labeled hMSCs in the same mice over time in vivo. Our results show that the volume of the region of signal loss due to iron-labeled cells diminished more slowly over time compared to the signal due to 19 F-labeled cells. This discrepancy is likely related to the fact that bystander cells can be labeled secondarily through the release of labels from dead stem cells; 42 although the bystander cells will contain much lower amounts of the label. Because of the large differences in sensitivity of iron or fluorine signal, iron-labeled bystander cells will still produce signal loss, whereas 19 F-labeled bystander cells may be undetectable. Several studies have pointed out that the signal loss produced by iron-labeled cells can greatly overestimate the presence of the viable transplanted cell population. 29, [42] [43] [44] The signal void caused by the presence of iron-labeled cells is similar to hypointense signal produced by bone, air, and hemorrhage. This is a major hurdle to the use of MRI to reliably identify iron-labeled cells after their transplantation. A major advantage of 19 F MRI is that the detection of the probe is specific to the labeled cells because of the lack of endogenous 19 F in the body. Therefore, unlike when using iron oxide nanoparticles, the signal is highly specific and interpretation is straightforward.
Use of the bSSFP sequence can be limited by banding artifacts that get more numerous at high magnetic fields. However, this artifact can be suppressed with shortened TRs (such as that used in this study) or by employing phase cycling.
Conclusion
In conclusion, we have shown that the bSSFP imaging sequence can be employed to detect and track fluorine-labeled human stem cells in vivo on 3D images. Furthermore, this work highlights the discrepancy in signal changes over time between 19 F-and iron-labeled cells. 19 F MRI provides an essential tool for researchers to study the main issues related to the use of hMSC using preclinical small animal models at high magnetic field.
